Cargando…
Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082299/ https://www.ncbi.nlm.nih.gov/pubmed/32206565 http://dx.doi.org/10.21037/tlcr.2019.11.14 |
| _version_ | 1783508318942134272 |
|---|---|
| author | Xu, Song-Tao Yin, Jia-Cheng Xi, Jun-Jie Wang, Qun Zhong, Wen-Zhao Wu, Yi-Long |
| author_facet | Xu, Song-Tao Yin, Jia-Cheng Xi, Jun-Jie Wang, Qun Zhong, Wen-Zhao Wu, Yi-Long |
| author_sort | Xu, Song-Tao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7082299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70822992020-03-23 Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply Xu, Song-Tao Yin, Jia-Cheng Xi, Jun-Jie Wang, Qun Zhong, Wen-Zhao Wu, Yi-Long Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2020-02 /pmc/articles/PMC7082299/ /pubmed/32206565 http://dx.doi.org/10.21037/tlcr.2019.11.14 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Xu, Song-Tao Yin, Jia-Cheng Xi, Jun-Jie Wang, Qun Zhong, Wen-Zhao Wu, Yi-Long Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title | Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title_full | Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title_fullStr | Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title_full_unstemmed | Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title_short | Treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected EGFR-mutant non-small cell lung cancer: author’s reply |
| title_sort | treatment failure patterns of adjuvant gefitinib therapy and minimal residual disease detection in resected egfr-mutant non-small cell lung cancer: author’s reply |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082299/ https://www.ncbi.nlm.nih.gov/pubmed/32206565 http://dx.doi.org/10.21037/tlcr.2019.11.14 |
| work_keys_str_mv | AT xusongtao treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply AT yinjiacheng treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply AT xijunjie treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply AT wangqun treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply AT zhongwenzhao treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply AT wuyilong treatmentfailurepatternsofadjuvantgefitinibtherapyandminimalresidualdiseasedetectioninresectedegfrmutantnonsmallcelllungcancerauthorsreply |